pipeline | autoimmune/inflammation | oncology
A Phase I healthy volunteer study for ALPN-101 has begun. ALPN-202 is targeted to file an IND later in 2019.
We are hosting a “Young Women in Science” event today for high school students from Seattle's @RooseveltHS and… twitter.com/i/web/status/11084…
About an hour ago
We'll be presenting at 10:20am EDT today (time has changed) at Oppenheimer's 29th Annual Healthcare Conference.
March 19, 2019 1:20 pm
© 2019 Alpine Immune Sciences. All Rights Reserved, Alpine Immune Sciences Inc.